5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one hydrochloride
| Title | Journal |
|---|---|
| Reduction and methylation of ziprasidone by glutathione, aldehyde oxidase, and thiol S-methyltransferase in humans: an in vitro study. | Xenobiotica; the fate of foreign compounds in biological systems 20121101 |
| Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats. | Progress in neuro-psychopharmacology & biological psychiatry 20121001 |
| A case of severe hyponatremia induced by duloxetine and ziprasidone. | Chinese medical journal 20121001 |
| Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics. | Experimental & molecular medicine 20120930 |
| Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study. | Journal of psychopharmacology (Oxford, England) 20120901 |
| Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis. | Expert opinion on drug safety 20120901 |
| Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome? | Journal of clinical psychopharmacology 20120801 |
| Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia. | Schizophrenia bulletin 20120701 |
| Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study. | Pharmacopsychiatry 20120701 |
| Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial. | International clinical psychopharmacology 20120701 |
| Single-dose ziprasidone associated with QT interval prolongation. | The American journal of emergency medicine 20120601 |
| The effect of ziprasidone on body weight and energy expenditure in female rats. | Metabolism: clinical and experimental 20120601 |
| Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state. | Pharmacopsychiatry 20120601 |
| Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials. | The Journal of clinical psychiatry 20120601 |
| In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations. | International journal of pharmaceutics 20120530 |
| Network-assisted investigation of antipsychotic drugs and their targets. | Chemistry & biodiversity 20120501 |
| The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state. | The Journal of clinical psychiatry 20120401 |
| Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data. | CNS drugs 20120401 |
| Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). | Cutis 20120401 |
| Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone. | European child & adolescent psychiatry 20120301 |
| Serum prolactin levels and the acute-phase efficacy in drug-naïve schizophrenia treated with ziprasidone and olanzapine (translated version). | East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan 20120301 |
| Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120201 |
| The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients. | Psychopharmacology 20120201 |
| Antipsychotic-induced psychotic-like syndrome and pathological smiling in an adolescent. | Journal of child and adolescent psychopharmacology 20120201 |
| Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. | Schizophrenia bulletin 20120101 |
| Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials. | Human psychopharmacology 20120101 |
| Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia. | Clinical schizophrenia & related psychoses 20120101 |
| Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophrenia. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101 |
| Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial. | Clinical neuropharmacology 20120101 |
| A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. | PloS one 20120101 |
| Three key antipsychotics lose patent protection. | Behavioral healthcare 20120101 |
| High-performance liquid chromatographic assay for ziprasidone in plasma samples: application to pharmacokinetic studies in rats. | Journal of chromatographic science 20120101 |
| The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder. | The Israel journal of psychiatry and related sciences 20120101 |
| Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients. | Pharmacological reports : PR 20120101 |
| Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. | BMC psychiatry 20120101 |
| Development of rapid and robust stability-indicating method for analysis of ziprasidone (hydrochloride and freebase) as drug substance and in medicines by UPLC. | Acta poloniae pharmaceutica 20120101 |
| Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry. | Biomedical chromatography : BMC 20111201 |
| Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect. | Pharmaceutical research 20111201 |
| Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats. | Xenobiotica; the fate of foreign compounds in biological systems 20111201 |
| Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism. | Progress in neuro-psychopharmacology & biological psychiatry 20111201 |
| Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile. | Clinical therapeutics 20111201 |
| Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. | Journal of clinical pharmacology 20111101 |
| Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC). | Pharmacoepidemiology and drug safety 20111101 |
| Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder. | Schizophrenia research 20111101 |
| Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. | The Journal of clinical psychiatry 20111001 |
| Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder. | Expert opinion on pharmacotherapy 20111001 |
| Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report. | Journal of clinical psychopharmacology 20111001 |
| Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study. | The international journal of neuropsychopharmacology 20110901 |
| Ziprasidone induced symptomatic bradycardia: a case report. | The Australian and New Zealand journal of psychiatry 20110901 |
| Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled Trials. | Pharmacotherapy 20110901 |
| Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients. | Journal of psychiatric research 20110801 |
| Outcome assessment of an antipsychotic drug algorithm: effects of the Mississippi State Hospital algorithm project. | Psychiatric services (Washington, D.C.) 20110801 |
| Digital Holter measurement of QT prolongation in ziprasidone overdose. | Clinical toxicology (Philadelphia, Pa.) 20110801 |
| Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. | Journal of psychopharmacology (Oxford, England) 20110701 |
| Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost. | American journal of therapeutics 20110701 |
| Molecular dynamics of the cryomilled base and hydrochloride ziprasidones by means of dielectric spectroscopy. | Journal of pharmaceutical sciences 20110701 |
| Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone. | Journal of pharmaceutical sciences 20110701 |
| Stability-indicating spectrofluorimetric method for the assay of ziprasidone in capsules. | Journal of fluorescence 20110701 |
| Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial. | Pharmacopsychiatry 20110701 |
| Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). | The Journal of clinical psychiatry 20110701 |
| Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone. | Journal of psychopharmacology (Oxford, England) 20110601 |
| QT interval duration and dispersion in children and adolescents treated with ziprasidone. | The Journal of clinical psychiatry 20110601 |
| Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study. | The American journal of psychiatry 20110601 |
| Drug safety evaluation of ziprasidone. | Expert opinion on drug safety 20110501 |
| The safety of atypical antipsychotics: does QTc provide all the answers? | Expert opinion on drug safety 20110501 |
| Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells. | Neuroscience research 20110401 |
| Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. | Schizophrenia research 20110401 |
| Ziprasidone for maintenance treatment of bipolar I disorder in adults. | Expert opinion on pharmacotherapy 20110401 |
| Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats. | Progress in neuro-psychopharmacology & biological psychiatry 20110330 |
| Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. | Schizophrenia bulletin 20110301 |
| Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. | The Journal of clinical psychiatry 20110301 |
| Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data. | Schizophrenia research 20110301 |
| Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder. | Journal of psychiatric practice 20110301 |
| Use of ziprasidone in patients with schizophrenia in four European countries. | European psychiatry : the journal of the Association of European Psychiatrists 20110301 |
| Switching among antipsychotics--focus on side effects. | Psychiatria Danubina 20110301 |
| Antipsychotic treatment--side-effect and/or metabolic syndrome. | Psychiatria Danubina 20110301 |
| Weight gain--as possible predictor of metabolic syndrome. | Psychiatria Danubina 20110301 |
| Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone. | The Journal of clinical psychiatry 20110301 |
| Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20110301 |
| Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review. | Expert review of clinical pharmacology 20110301 |
| Third degree heart block following intramuscular ziprasidone. | Schizophrenia research 20110201 |
| Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). | The American journal of psychiatry 20110201 |
| Ziprasidone and the relative risk of diabetes. | The British journal of psychiatry : the journal of mental science 20110201 |
| What can large simple trials do for psychiatry? | The American journal of psychiatry 20110201 |
| Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone. | Behavioural brain research 20110120 |
| Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics. | Molecular psychiatry 20110101 |
| Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs. | Biological research for nursing 20110101 |
| A thermodynamic-based approach to analyzing a highly solvating polymorphic system: the desolvation window method. | Journal of pharmaceutical sciences 20110101 |
| Differential effects of ziprasidone and haloperidol on immobilization-stress-induced CRF mRNA expression in the hypothalamic paraventricular nucleus of rats. | Neuropsychobiology 20110101 |
| Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110101 |
| Risperidone versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20110101 |
| Switching among antipsychotics in everyday clinical practice: focus on ziprasidone. | Postgraduate medicine 20110101 |
| Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) or Hashimoto's encephalopathy: a case and review. | Psychosomatics 20110101 |
| Development and validation of an HPLC method for determination of ziprasidone and its impurities in pharmaceutical dosage forms. | Journal of AOAC International 20110101 |
| Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial. | BMC psychiatry 20110101 |
| Cytogenetic effects of valproic acid and ziprasidone in human lymphocyte cultures. | Neuropsychobiology 20110101 |
| Pisa syndrome and laryngeal dystonia induced by novel antipsychotics. | The Israel journal of psychiatry and related sciences 20110101 |
| Use of a new ziprasidone-selective electrode in mixed solvents and its application in the analysis of pharmaceuticals and biological fluids. | Sensors (Basel, Switzerland) 20110101 |
| Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses. | Neuro endocrinology letters 20110101 |
| Pediatric ziprasidone ingestions. | Journal of medical toxicology : official journal of the American College of Medical Toxicology 20101201 |
| Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101201 |
| A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| A case of catatonia successfully treated with ziprasidone, in a patient with DSM-IV delusional disorder. | Journal of clinical psychopharmacology 20101201 |
| Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials. | Journal of clinical psychopharmacology 20101201 |
| Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. | Schizophrenia research 20101101 |
| Bitter pills for drug companies. | BMJ (Clinical research ed.) 20100917 |
| Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up. | European journal of clinical pharmacology 20100901 |
| Strategies for successful clinical management of schizophrenia with ziprasidone. | Expert opinion on pharmacotherapy 20100901 |
| Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder. | Pharmacotherapy 20100901 |
| The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats. | Clinics (Sao Paulo, Brazil) 20100901 |
| Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies. | Progress in neuro-psychopharmacology & biological psychiatry 20100816 |
| A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial. | Journal of clinical psychopharmacology 20100801 |
| Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone. | Pharmacopsychiatry 20100801 |
| Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome. | Journal of clinical psychopharmacology 20100801 |
| Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial? | Journal of clinical psychopharmacology 20100801 |
| Characteristics and mortality among hospitalized patients treated with intramuscular antipsychotics: analysis of a United States hospital database. | Current drug safety 20100702 |
| Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. | Schizophrenia research 20100701 |
| Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults. | Expert review of neurotherapeutics 20100701 |
| Protracted, dose-dependent weight loss after addition of ziprasidone to a stable regimen of clozapine. | Human psychopharmacology 20100701 |
| Electroanalytical characteristics of antipsychotic drug ziprasidone and its determination in pharmaceuticals and serum samples on solid electrodes. | Talanta 20100630 |
| Ziprasidone-induced spontaneous orgasm. | Journal of psychopharmacology (Oxford, England) 20100601 |
| Safety of the electroconvulsive therapy-ziprasidone combination. | The journal of ECT 20100601 |
| Serotonin syndrome caused by ziprasidone alone. | Psychiatry and clinical neurosciences 20100601 |
| [Descriptive analysis of the use of atypical antipsychotics under compassionate-use in a health area in Ferrol (La Coruña, Spain)]. | Neurologia (Barcelona, Spain) 20100601 |
| Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST). | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100501 |
| Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia. | Clinical neuropharmacology 20100501 |
| Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study. | Journal of psychopharmacology (Oxford, England) 20100401 |
| Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies. | Journal of affective disorders 20100401 |
| Symptomatic bradycardia with oral aripiprazole and oral ziprasidone. | The Annals of pharmacotherapy 20100401 |
| Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind study. | Journal of clinical psychopharmacology 20100401 |
| A nearly overlooked mild case of ziprasidone-induced lingual dystonia. | Journal of clinical psychopharmacology 20100401 |
| Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice. | Biochemical and biophysical research communications 20100305 |
| Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro. | Journal of psychopharmacology (Oxford, England) 20100301 |
| Pediatric uptake of a newly available antipsychotic medication. | Pediatrics 20100301 |
| Respiratory failure following isolated ziprasidone ingestion in a toddler. | Journal of medical toxicology : official journal of the American College of Medical Toxicology 20100301 |
| Ziprasidone as a possible cause of cleft palate in a newborn. | Psychiatria Danubina 20100301 |
| Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder. | Clinical therapeutics 20100301 |
| Antipsychotics in pregnancy. | Journal of psychiatric and mental health nursing 20100301 |
| How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone. | Journal of psychiatric practice 20100301 |
| Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone. | Psychiatry research 20100227 |
| Torsade de pointes after ziprasidone overdose with coingestants. | Journal of clinical psychopharmacology 20100201 |
| Free your MIND and the rest will follow: decoding delirium in the intensive care unit. | Critical care medicine 20100201 |
| Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. | Critical care medicine 20100201 |
| Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder. | Pharmacotherapy 20100201 |
| Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. | The Journal of clinical psychiatry 20100201 |
| Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. | Psychiatric services (Washington, D.C.) 20100201 |
| Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission. | Journal of psychiatric research 20100101 |
| Amisulpride versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| Quetiapine versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| The successful treatment of mania due to acquired immunodeficiency syndrome using ziprasidone: a case series. | The Journal of neuropsychiatry and clinical neurosciences 20100101 |
| Olanzapine versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. | BMC psychiatry 20100101 |
| A possible case of mixed mania due to neurosarcoidosis treated successfully with methylprednisolone and ziprasidone: another example of frontal-subcortical disinhibition? | General hospital psychiatry 20100101 |
| Clozapine versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20100101 |
| [Practical aspects of the use of ziprasidone in schizophrenia]. | Psychiatria polska 20100101 |
| Ziprasidone-related oculogyric crisis in an adult. | Clinical neurology and neurosurgery 20091201 |
| Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder. | Schizophrenia research 20091201 |
| Vocal tics associated with ziprasidone. | Journal of clinical psychopharmacology 20091201 |
| Brugada syndrome unmasked by lithium. | Southern medical journal 20091201 |
| Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder. | Journal of child and adolescent psychopharmacology 20091201 |
| Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. | Behavioural brain research 20091105 |
| Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia. | Molecular psychiatry 20091101 |
| The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases. | Journal of psychopharmacology (Oxford, England) 20091101 |
| Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol. | Schizophrenia research 20091101 |
| Ziprasidone monotherapy in bipolar II depression: an open trial. | Journal of affective disorders 20091101 |
| P wave and QT changes among inpatients with schizophrenia after parenteral ziprasidone administration. | Pharmacological research 20091101 |
| Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. | The American journal of psychiatry 20091101 |
| Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. | The international journal of neuropsychopharmacology 20091001 |
| The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study. | Pharmacoepidemiology and drug safety 20090901 |
| Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. | International clinical psychopharmacology 20090901 |
| Electrocardiographic monitoring for QT prolongation in patients treated with ziprasidone--a claims database approach. | Pharmacoepidemiology and drug safety 20090901 |
| Pregnancy and atypical antipsychotics. | Psychiatria Danubina 20090901 |
| Activation induced by high-dose ziprasidone: a case report. | The Journal of clinical psychiatry 20090901 |
| Ziprasidone in Black patients with schizophrenia: analysis of four short-term, double-blind studies. | CNS spectrums 20090901 |
| FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse. | JAMA 20090826 |
| Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study. | Molecular psychiatry 20090801 |
| Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study. | Schizophrenia research 20090801 |
| Using oral ziprasidone effectively: the food effect and dose-response. | Advances in therapy 20090801 |
| [Pharmacokinetics and relative bioavailability of ziprasidone tablets in Chinese healthy volunteers]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20090801 |
| In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. | Journal of psychiatric research 20090701 |
| Unintentional ingestion of ziprasidone in a 22-month-old. | Pediatric emergency care 20090701 |
| How dosing of ziprasidone in a state hospital system differs from product labeling. | The Journal of clinical psychiatry 20090701 |
| Ziprasidone-induced angioedema: a case report. | The Journal of clinical psychiatry 20090701 |
| Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials. | Schizophrenia research 20090601 |
| Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article. | Journal of neurosurgery. Pediatrics 20090601 |
| Targeting cognition in schizophrenia research: from etiology to treatment. | The American journal of psychiatry 20090601 |
| A systematic review of cardiovascular effects after atypical antipsychotic medication overdose. | The American journal of emergency medicine 20090601 |
| Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. | Journal of medical economics 20090601 |
| Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia. | The Journal of clinical psychiatry 20090601 |
| Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania. | The Journal of clinical psychiatry 20090601 |
| Atypical antipsychotic drugs and the risk of sudden cardiac death. | The New England journal of medicine 20090514 |
| Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. | Journal of psychopharmacology (Oxford, England) 20090501 |
| Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study. | Schizophrenia research 20090501 |
| Weight effects associated with antipsychotics: a comprehensive database analysis. | Schizophrenia research 20090501 |
| Akathisia and second-generation antipsychotic drugs. | Current opinion in psychiatry 20090501 |
| Switch to ziprazidone treatment is associated with changes in MMN amplitude: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20090430 |
| Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. | The Journal of clinical psychiatry 20090421 |
| The use of ziprasidone in clinical practice: analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey. | European psychiatry : the journal of the Association of European Psychiatrists 20090401 |
| Low concentration of ziprasidone in human milk: a case report. | The international journal of neuropsychopharmacology 20090401 |
| Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia. | Human psychopharmacology 20090401 |
| How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. | European psychiatry : the journal of the Association of European Psychiatrists 20090401 |
| Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study. | The Journal of clinical psychiatry 20090401 |
| Pediatric ziprasidone overdose. | Pediatric emergency care 20090401 |
| A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic. | Community mental health journal 20090201 |
| Chronic Pisa syndrome associated with switching antipsychotics from olanzapine to ziprasidone. | Progress in neuro-psychopharmacology & biological psychiatry 20090201 |
| Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats. | Journal of psychiatric research 20090101 |
| Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial. | The Journal of clinical psychiatry 20090101 |
| A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20090101 |
| Extrapyramidal side effects: could you identify them in the emergency department? | Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association 20090101 |
| Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials. | BMC psychiatry 20090101 |
| Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. | The Cochrane database of systematic reviews 20090101 |
| The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia. | Clinical neuropharmacology 20090101 |
| Tardive dyskinesia in a patient treated with quetiapine. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| A failed case of weaning from a mechanical ventilator with lorazepam successfully accomplished by ziprasidone. | General hospital psychiatry 20090101 |
| Mortality in patients with dementia treated with atypical antipsychotics (olanzapine, quetiapine and ziprasidone). | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101 |
| Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade. | Psychopharmacology bulletin 20090101 |
| Ziprasidone versus other atypical antipsychotics for schizophrenia. | The Cochrane database of systematic reviews 20090101 |
| New-onset vascular mania in a patient with chronic depression. | The Journal of neuropsychiatry and clinical neurosciences 20090101 |
| Ziprasidone induced tardive cervical dystonia. | Psychopharmacology bulletin 20090101 |
| Therapeutic drug monitoring of ziprasidone in a clinical treatment setting. | Therapeutic drug monitoring 20081201 |
| Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). | Journal of clinical psychopharmacology 20081201 |
| Ziprasidone-associated mania in Korean schizophrenic patient. | Journal of clinical psychopharmacology 20081201 |
| The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment. | Bipolar disorders 20081201 |
| A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment. | Schizophrenia research 20081001 |
| Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study. | Journal of clinical psychopharmacology 20081001 |
| Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder. | Journal of child and adolescent psychopharmacology 20081001 |
| Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia. | Psychiatry and clinical neurosciences 20081001 |
| Long-term improvement in efficacy and safety after switching to ziprasidone in stable outpatients with schizophrenia. | CNS spectrums 20081001 |
| Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice. | Brain research bulletin 20080930 |
| The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. | European journal of pharmacology 20080911 |
| Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. | Schizophrenia research 20080801 |
| Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency. | Progress in neuro-psychopharmacology & biological psychiatry 20080801 |
| Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats. | Journal of psychopharmacology (Oxford, England) 20080701 |
| Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry. | Biomedical chromatography : BMC 20080701 |
| Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders. | Schizophrenia research 20080701 |
| Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. | International clinical psychopharmacology 20080701 |
| Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. | The Journal of clinical psychiatry 20080701 |
| Profound hypothermia secondary to normal ziprasidone use. | The American journal of emergency medicine 20080701 |
| Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080601 |
| Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation. | The Annals of pharmacotherapy 20080601 |
| Clinical experiences and clinical trials. | CNS spectrums 20080601 |
| Administration of ziprasidone for 10 days increases cocaine toxicity in mice. | Human & experimental toxicology 20080601 |
| Did CATIE influence antipsychotic use? | Psychiatric services (Washington, D.C.) 20080501 |
| What CATIE found: results from the schizophrenia trial. | Psychiatric services (Washington, D.C.) 20080501 |
| Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080401 |
| Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. | Acta psychiatrica Scandinavica 20080401 |
| Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. | The Journal of clinical psychiatry 20080401 |
| Ziprasidone-induced hyperprolactinemia: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20080401 |
| Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia. | Journal of clinical psychopharmacology 20080401 |
| High-dose ziprasidone monotherapy in bipolar I disorder patients with depressed or mixed episodes. | Journal of clinical psychopharmacology 20080401 |
| [Ziprasidone in Parkinsonian dopamine psychosis]. | Revista de neurologia 20080401 |
| Problems with CATIE. Phase 1: Looking back--what the clinician needs to know. | Connecticut medicine 20080401 |
| Pattern of ziprasidone exposures reported to Texas poison centers, 2001-2005. | Human & experimental toxicology 20080401 |
| Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. | Lancet (London, England) 20080329 |
| Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation. | Behavioural brain research 20080305 |
| Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats. | Journal of psychopharmacology (Oxford, England) 20080301 |
| Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat. | Behavioural pharmacology 20080301 |
| Urinary retention associated with ziprasidone: a case report. | The Journal of clinical psychiatry 20080301 |
| Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease. | Progress in neuro-psychopharmacology & biological psychiatry 20080215 |
| Determination of Ziprasidone in pharmaceutical formulations by capillary zone electrophoresis. | Journal of pharmaceutical and biomedical analysis 20080213 |
| A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. | The Journal of clinical psychiatry 20080201 |
| Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. | Schizophrenia research 20080101 |
| The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. | Progress in neuro-psychopharmacology & biological psychiatry 20080101 |
| Use of antipsychotics to treat cocaine toxicity? | Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20080101 |
| Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. | Journal of psychiatric practice 20080101 |
| Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone. | The Journal of neuropsychiatry and clinical neurosciences 20080101 |
| The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics. | The Journal of clinical psychiatry 20080101 |
| The use of atypical antipsychotics after traumatic brain injury. | The Journal of head trauma rehabilitation 20080101 |
| Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology. | Psychotherapy and psychosomatics 20080101 |
| Ziprasidone-induced tardive laryngeal dystonia: a case report. | General hospital psychiatry 20080101 |
| The use of atypical antipsychotics in pediatric bipolar disorder. | The Journal of clinical psychiatry 20080101 |
| Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. | The Journal of clinical psychiatry 20080101 |
| Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders. | The Journal of clinical psychiatry 20080101 |
| Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder: a retrospective comparative study. | Clinical drug investigation 20080101 |
| Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial. | Clinical neuropharmacology 20080101 |
| Ziprasidone in the treatment of affective disorders: a review. | CNS neuroscience & therapeutics 20080101 |
| A possible case of Capgras syndrome after a right anterior cerebral artery cerebrovascular accident treated successfully with mirtazapine. | The Journal of neuropsychiatry and clinical neurosciences 20080101 |
| Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists. | Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20071201 |
| Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. | Journal of clinical psychopharmacology 20071201 |
| QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine. | Journal of medical toxicology : official journal of the American College of Medical Toxicology 20071201 |
| A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. | Bipolar disorders 20071201 |
| Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. | The Journal of clinical psychiatry 20071201 |
| Ziprasidone in adolescents with autism: an open-label pilot study. | Journal of child and adolescent psychopharmacology 20071201 |
| Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study. | International clinical psychopharmacology 20071101 |
| Clinical relevance of relative receptor binding affinity: quetiapine and ziprasidone as examples. | Journal of psychiatric practice 20071101 |
| Treatment of bipolar disorder: the evolving role of atypical antipsychotics. | The American journal of managed care 20071101 |
| Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015 |
| The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. | Psychopharmacology 20071001 |
| The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features. | Progress in neuro-psychopharmacology & biological psychiatry 20071001 |
| The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care. | Progress in neuro-psychopharmacology & biological psychiatry 20071001 |
| Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial. | Progress in neuro-psychopharmacology & biological psychiatry 20071001 |
| Characterization of atypical antipsychotic drugs by a late decrease of striatal alpha1 spectral power in the electropharmacogram of freely moving rats. | British journal of pharmacology 20071001 |
| Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone. | Journal of clinical psychopharmacology 20071001 |
| Managing the acutely agitated and psychotic patient. | CNS spectrums 20071001 |
| Practical strategies for assessing and stabilizing bipolar patients in urgent situations. | The Journal of clinical psychiatry 20071001 |
| Show me the evidence: using number needed to treat. | Southern medical journal 20070901 |
| Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study. | The Journal of clinical psychiatry 20070901 |
| The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. | Schizophrenia research 20070801 |
| Impairment in error monitoring predicts poor executive function in schizophrenia patients. | Schizophrenia research 20070801 |
| Ziprasidone, diazepam, or the combination for prevention of cocaine toxicity in a mouse model. | Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20070801 |
| Metabolic effects of the atypical antipsychotics. | Southern medical journal 20070801 |
| A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed. | Journal of child and adolescent psychopharmacology 20070801 |
| Ziprasidone-associated mania in a case of obssessive-compulsive disorder. | CNS spectrums 20070801 |
| Possible case of allopurinol causing relapse of psychosis. | Schizophrenia research 20070701 |
| Urticaria and angio-oedema due to ziprasidone. | Journal of psychopharmacology (Oxford, England) 20070701 |
| Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. | The Journal of clinical psychiatry 20070701 |
| Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment. | Molecular psychiatry 20070601 |
| Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone. | Bone marrow transplantation 20070601 |
| Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. | Archives of general psychiatry 20070601 |
| A different mechanism to understand activation/sedation side effects of ziprasidone. | The Journal of clinical psychiatry 20070601 |
| Ziprasidone-induced acute laryngeal dystonia. | Progress in neuro-psychopharmacology & biological psychiatry 20070509 |
| Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications. | Bipolar disorders 20070501 |
| Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels. | Pharmacopsychiatry 20070501 |
| Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial. | European psychiatry : the journal of the Association of European Psychiatrists 20070401 |
| Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports. | Journal of clinical psychopharmacology 20070401 |
| Ziprasidone-associated galactorrhea in an adolescent female. | Journal of child and adolescent psychopharmacology 20070401 |
| Ziprasidone for maladaptive behavior and attention-deficit/hyperactivity disorder symptoms in autistic disorder. | Journal of child and adolescent psychopharmacology 20070401 |
| High-dose ziprasidone-induced acute dystonia. | Progress in neuro-psychopharmacology & biological psychiatry 20070330 |
| Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone. | Progress in neuro-psychopharmacology & biological psychiatry 20070330 |
| Use of ziprasidone in patients with fibromyalgia: a case series. | Rheumatology international 20070301 |
| Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070301 |
| Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. | The American journal of psychiatry 20070301 |
| Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. | The international journal of neuropsychopharmacology 20070201 |
| Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing. | Clinical neurology and neurosurgery 20070201 |
| Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam. | The Journal of the Association of Physicians of India 20070201 |
| Does antipsychotic polypharmacy increase the risk for metabolic syndrome? | Schizophrenia research 20070101 |
| Datapoints: The ups and downs of dosing second-generation antipsychotics. | Psychiatric services (Washington, D.C.) 20070101 |
| A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070101 |
| Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study. | Clinical neuropharmacology 20070101 |
| Treatment refractory psychosis remitted upon treatment with continuous positive airway pressure: a case report. | Psychopharmacology bulletin 20070101 |
| Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia. | Behavioural neurology 20070101 |
| Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101 |
| 5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes. | Clinical and experimental pharmacology & physiology 20070101 |
| Comments on the report of neuroleptic malignant syndrome induced by ziprasidone. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20070101 |
| Cocaine use as a risk factor for ziprasidone-induced acute dystonia. | General hospital psychiatry 20070101 |
| Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia. | Journal of the American Pharmacists Association : JAPhA 20070101 |
| Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the longitudinal study Ziprasidone Extended Use in Schizophrenia (ZEUS). | Actas espanolas de psiquiatria 20070101 |
| Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials. | CNS drug reviews 20070101 |
| Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trial. | Clinical drug investigation 20070101 |
| Ziprasidone security in overdose: one case report. | Actas espanolas de psiquiatria 20070101 |
| Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder. | CNS drugs 20070101 |
| Prospective observational multi-poison center study of ziprasidone exposures. | Clinical toxicology (Philadelphia, Pa.) 20070101 |
| The effect of food on the absorption of oral ziprasidone. | Psychopharmacology bulletin 20070101 |
| A case report with ziprasidone-induced catatonic symptoms. | The Journal of neuropsychiatry and clinical neurosciences 20070101 |
| Ziprasidone-associated depressive state in schizophrenic patients. | Clinical neuropharmacology 20070101 |
| Ziprasidone-induced tardive dyskinesia in a patient without known risk factors. | The National medical journal of India 20070101 |
| A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis. | Progress in neuro-psychopharmacology & biological psychiatry 20061230 |
| Ziprasidone in the treatment of Parkinson's disease psychosis. | European psychiatry : the journal of the Association of European Psychiatrists 20061201 |
| Atypical antipsychotic drugs and organization of long-term semantic memory: multidimensional scaling and cluster analyses of category fluency performance in schizophrenia. | The international journal of neuropsychopharmacology 20061201 |
| A model of anticholinergic activity of atypical antipsychotic medications. | Schizophrenia research 20061201 |
| Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. | Journal of clinical psychopharmacology 20061201 |
| Treatment of psychosis: 30 years of progress. | Journal of clinical pharmacy and therapeutics 20061201 |
| A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents. | Journal of child and adolescent psychopharmacology 20061201 |
| [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20061201 |
| Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics. | Psychiatry research 20061115 |
| Early changes of plasma lipids during treatment with atypical antipsychotics. | International clinical psychopharmacology 20061101 |
| Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity? | Schizophrenia research 20061001 |
| Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060901 |
| A model for antipsychotic-induced obesity in the male rat. | Psychopharmacology 20060901 |
| Probable association between ziprasidone and worsening hypertension. | Pharmacotherapy 20060901 |
| The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone. | The Journal of clinical psychiatry 20060901 |
| Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats. | The Journal of pharmacology and experimental therapeutics 20060801 |
| The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. | Psychopharmacology 20060801 |
| Long-term use of atypical antipsychotics in bipolar disorder. | Pharmacotherapy 20060801 |
| Ziprasidone: efficacy and safety in patients with bipolar disorder. | Expert review of neurotherapeutics 20060801 |
| Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade. | CNS & neurological disorders drug targets 20060801 |
| Advanced pediatric psychopharmacology. | Journal of child and adolescent psychopharmacology 20060801 |
| Ziprasidone-associated pedal edema in the treatment of schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20060701 |
| Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060701 |
| Acute dystonia after initial doses of ziprasidone: a case report. | Progress in neuro-psychopharmacology & biological psychiatry 20060601 |
| Ziprasidone in the treatment of delayed carbon monoxide encephalopathy. | Progress in neuro-psychopharmacology & biological psychiatry 20060601 |
| Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. | Pharmacotherapy 20060601 |
| Electrocardiographic changes with ziprasidone. | Journal of the American Academy of Child and Adolescent Psychiatry 20060601 |
| Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents. | Journal of the American Academy of Child and Adolescent Psychiatry 20060601 |
| Ziprasidone in bipolar disorder. | Expert opinion on pharmacotherapy 20060601 |
| Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study. | International clinical psychopharmacology 20060501 |
| Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine. | Behavioural pharmacology 20060501 |
| Injectable atypical antipsychotics for agitation in borderline personality disorder. | Pharmacopsychiatry 20060501 |
| Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma. | Biomedical chromatography : BMC 20060401 |
| Effect of initial ziprasidone dose on length of therapy in schizophrenia. | Schizophrenia research 20060401 |
| Effect of initial ziprasidone dose on treatment persistence in schizophrenia. | Schizophrenia research 20060401 |
| Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. | The American journal of psychiatry 20060401 |
| Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. | The American journal of psychiatry 20060401 |
| A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. | Journal of clinical psychopharmacology 20060401 |
| Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data. | The Journal of clinical psychiatry 20060401 |
| Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome. | The Journal of clinical psychiatry 20060401 |
| Intramuscular ziprasidone: an effective agent for sedation of the agitated ED patient. | The American journal of emergency medicine 20060301 |
| Sudden akathisia after a ziprasidone dose reduction. | The American journal of psychiatry 20060301 |
| Prescribing behavior and marketing practices. | Psychiatric services (Washington, D.C.) 20060301 |
| Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. | The Journal of nervous and mental disease 20060301 |
| Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. | The Journal of clinical psychiatry 20060201 |
| Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder. | The Journal of clinical psychiatry 20060201 |
| Antipsychotic drugs and schizophrenia. | The New England journal of medicine 20060119 |
| Block of hERG channel by ziprasidone: biophysical properties and molecular determinants. | Biochemical pharmacology 20060112 |
| Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia. | International clinical psychopharmacology 20060101 |
| Urinary hesitancy and retention caused by ziprasidone. | International clinical psychopharmacology 20060101 |
| The effects of ziprasidone on regional c-Fos expression in the rat forebrain. | Psychopharmacology 20060101 |
| Ziprasidone- and lithium-induced neuroleptic malignant syndrome. | The Annals of pharmacotherapy 20060101 |
| Ziprasidone-induced priapism requiring surgical treatment. | European psychiatry : the journal of the Association of European Psychiatrists 20060101 |
| Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia. | General hospital psychiatry 20060101 |
| Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system. | Psychiatric services (Washington, D.C.) 20060101 |
| Interpreting the results of the CATIE study. | Psychiatric services (Washington, D.C.) 20060101 |
| Interpreting the results of the CATIE study. | Psychiatric services (Washington, D.C.) 20060101 |
| Interpreting the results of the CATIE study. | Psychiatric services (Washington, D.C.) 20060101 |
| Real-life switching strategies with second-generation antipsychotics. | The Journal of clinical psychiatry 20060101 |
| Methodological issues in a comparative study of ziprasidone and risperidone. | The Journal of clinical psychiatry 20060101 |
| A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania. | European psychiatry : the journal of the Association of European Psychiatrists 20060101 |
| Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
| Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders. | The American journal on addictions 20060101 |
| Torsades de pointes associated with ziprasidone. | Psychosomatics 20060101 |
| Self-mutilation of fingers after cervical spinal cord injury. | Psychosomatics 20060101 |
| Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
| [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment]. | Actas espanolas de psiquiatria 20060101 |
| An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia. | Dementia and geriatric cognitive disorders 20060101 |
| Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. | CNS drugs 20060101 |
| Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain. | Clinical drug investigation 20060101 |
| The bane of a silent illness: when Wilson's disease takes its course. | International journal of psychiatry in medicine 20060101 |
| An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics. | Toxicology 20051215 |
| Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat. | Neuropharmacology 20051201 |
| Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. | International psychogeriatrics 20051201 |
| Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam. | Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20051201 |
| Drugs that inhibit oxidation reactions catalyzed by aldehyde oxidase do not inhibit the reductive metabolism of ziprasidone to its major metabolite, S-methyldihydroziprasidone: an in vitro study. | Journal of clinical psychopharmacology 20051201 |
| Parkinsonism with intramuscular ziprasidone. | The American journal of psychiatry 20051201 |
| Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service. | The American journal of geriatric pharmacotherapy 20051201 |
| Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20051123 |
| Ziprasidone overdose: cases recorded in the database of Pfizer-Spain and literature review. | Pharmacotherapy 20051101 |
| Tardive dystonia associated with ziprasidone. | The American journal of psychiatry 20051101 |
| Ziprasidone therapy for post-traumatic stress disorder. | Journal of psychiatry & neuroscience : JPN 20051101 |
| From clinical research to clinical practice: a 4-year review of ziprasidone. | CNS spectrums 20051101 |
| Applying parsimony to 'An African patient with ziprasidone intolerance'. | The Journal of clinical psychiatry 20051101 |
| Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone. | The Annals of pharmacotherapy 20051001 |
| Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. | Journal of clinical psychopharmacology 20051001 |
| Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series. | Cephalalgia : an international journal of headache 20051001 |
| Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. | The American journal of psychiatry 20051001 |
| Atypical antipsychotics: special formulations for acute agitation. | Journal of psychosocial nursing and mental health services 20051001 |
| Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20051001 |
| Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. | The New England journal of medicine 20050922 |
| Ziprasidone decreases cortisol excretion in healthy subjects. | British journal of clinical pharmacology 20050901 |
| Best clinical practice with ziprasidone IM: update after 2 years of experience. | CNS spectrums 20050901 |
| Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20050901 |
| Atypical antipsychotics in the management of delirium: a review of the empirical literature. | Palliative & supportive care 20050901 |
| Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. | Journal of clinical psychopharmacology 20050801 |
| Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient. | International journal of geriatric psychiatry 20050801 |
| Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia. | The American journal of psychiatry 20050801 |
| Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects. | The Journal of clinical psychiatry 20050801 |
| Ziprasidone and hypomania. | CNS spectrums 20050801 |
| Ziprasidone-induced tardive dyskinesia. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050801 |
| Characterization of a novel metabolite intermediate of ziprasidone in hepatic cytosolic fractions of rat, dog, and human by ESI-MS/MS, hydrogen/deuterium exchange, and chemical derivatization. | Drug metabolism and disposition: the biological fate of chemicals 20050701 |
| The highest intentional ziprasidone overdose was not fatal. | Acta psychiatrica Scandinavica 20050701 |
| Cerebral cortical gray expansion associated with two second-generation antipsychotics. | Biological psychiatry 20050701 |
| Methodological concerns in a trial of ziprasidone and olanzapine. | The American journal of psychiatry 20050701 |
| Methodological concerns in a trial of ziprasidone and olanzapine. | The American journal of psychiatry 20050701 |
| A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients. | The Journal of clinical psychiatry 20050701 |
| Three-year experience with ziprasidone exposures. | The American journal of emergency medicine 20050701 |
| Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. | Pharmacoepidemiology and drug safety 20050601 |
| Antipsychotic drug-induced weight gain: development of an animal model. | International journal of obesity (2005) 20050601 |
| Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers. | Journal of clinical pharmacology 20050601 |
| An African patient with ziprasidone intolerance. | The Journal of clinical psychiatry 20050601 |
| Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release. | Drug metabolism and pharmacokinetics 20050601 |
| The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro. | Neuro endocrinology letters 20050601 |
| Bipolar disorder. | Clinical evidence 20050601 |
| Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats. | Behavioural brain research 20050528 |
| FDA warns antipsychotic drugs may be risky for elderly. | JAMA 20050525 |
| Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. | Brain research 20050510 |
| Ziprasidone pretreatment attenuates the lethal effects of cocaine in a mouse model. | Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 20050501 |
| Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. | Psychopharmacology 20050401 |
| Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detection. | Therapeutic drug monitoring 20050401 |
| Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease? | Human psychopharmacology 20050401 |
| Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer? | Current opinion in pediatrics 20050401 |
| Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone. | Journal of psychopharmacology (Oxford, England) 20050301 |
| Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine. | International clinical psychopharmacology 20050301 |
| D2-blockade and possible ziprasidone-induced galactorrhea. | International clinical psychopharmacology 20050301 |
| Ziprasidone-induced acute dystonia. | The American journal of psychiatry 20050301 |
| Ziprasidone as an augmenting agent in the treatment of anxiety-spectrum disorders. | CNS spectrums 20050301 |
| The treatment of mixed states and the risk of switching to depression. | European psychiatry : the journal of the Association of European Psychiatrists 20050301 |
| Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats. | Psychopharmacology 20050201 |
| New onset of diabetes mellitus with ziprasidone: a case report. | The Journal of clinical psychiatry 20050201 |
| Ziprasidone-induced galactorrhea: a case report. | Neuro endocrinology letters 20050201 |
| Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness. | Expert opinion on pharmacotherapy 20050201 |
| Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study. | Journal of the American Academy of Child and Adolescent Psychiatry 20050101 |
| Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol. | Progress in neuro-psychopharmacology & biological psychiatry 20050101 |
| Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study. | General hospital psychiatry 20050101 |
| Blood dyscrasia with quetiapine and ziprasidone. | Psychosomatics 20050101 |
| Ziprasidone-associated mania: a review and report of 2 additional cases. | Clinical neuropharmacology 20050101 |
| 12,800-mg ziprasidone overdose without significant ECG changes. | General hospital psychiatry 20050101 |
| Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone. | General hospital psychiatry 20050101 |
| The dosing of atypical antipsychotics. | Psychosomatics 20050101 |
| Additive effects of ziprasidone and D,L-sotalol on the action potential in rabbit Purkinje fibres and on the hERG potassium current. | Journal of pharmacological and toxicological methods 20050101 |
| Atypical antipsychotics: newer options for mania and maintenance therapy. | Bipolar disorders 20050101 |
| Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review. | CNS drugs 20050101 |
| Use of ziprasidone in parkinsonian patients with psychosis. | Clinical neuropharmacology 20050101 |
| Ziprasidone for agitation or psychosis in dementia: four cases. | International journal of psychiatry in medicine 20050101 |
| The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. | Medical hypotheses 20050101 |
| A typical mood stabilizers: a 'typical role for atypical antipsychotics. | Acta psychiatrica Scandinavica. Supplementum 20050101 |
| Ziprasidone: from pharmacology to the clinical practice. One year of experience. | Actas espanolas de psiquiatria 20050101 |
| Uniformity of ionization response of structurally diverse analytes using a chip-based nanoelectrospray ionization source. | Rapid communications in mass spectrometry : RCM 20050101 |
| Pharmacokinetics and therapeutics of acute intramuscular ziprasidone. | Clinical pharmacokinetics 20050101 |
| Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study. | Clinical neuropharmacology 20050101 |
| Ziprasidone and psychosis in Parkinson disease. | Clinical neuropharmacology 20050101 |
| Ziprasidone overdose: cardiac safety. | Actas espanolas de psiquiatria 20050101 |
| Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patients. | Clinical neuropharmacology 20050101 |
| Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. | BMC medicine 20050101 |
| [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities]. | Przeglad lekarski 20050101 |
| Pharmacology of antipsychotics in the elderly: a focus on atypicals. | Journal of the American Geriatrics Society 20041201 |
| Optimizing atypical antipsychotic treatment strategies in the elderly. | Journal of the American Geriatrics Society 20041201 |
| An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. | Controlled clinical trials 20041201 |
| Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain. | Progress in neuro-psychopharmacology & biological psychiatry 20041201 |
| Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial. | The Journal of clinical psychiatry 20041201 |
| [Misdiagnosed PTSD and zeldox pharmacotherapy in case of a political prisoner]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201 |
| Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat. | European journal of pharmacology 20041128 |
| [Risk of QTc prolongation due to combination of ziprasidone and quetiapine]. | Psychiatrische Praxis 20041101 |
| [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey]. | Psychiatrische Praxis 20041101 |
| Ziprasidone: first year experience in a hospital setting. | Journal of psychiatric practice 20041101 |
| Tardive dyskinesia in 2 patients treated with ziprasidone. | Journal of psychiatry & neuroscience : JPN 20041101 |
| Acute dystonic reaction with moderate-dose ziprasidone. | Journal of clinical psychopharmacology 20041001 |
| The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research. | Bipolar disorders 20041001 |
| Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. | The American journal of psychiatry 20041001 |
| Prolactin elevation with ziprasidone. | The American journal of psychiatry 20041001 |
| Atypical antipsychotics: matching receptor profile to individual patient's clinical profile. | CNS spectrums 20041001 |
| [Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease]. | Revista de neurologia 20041001 |
| The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning. | Postgraduate medicine 20041001 |
| Intravenous ziprasidone for treatment of delirium in the intensive care unit. | Anesthesiology 20040901 |
| Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services. | The Journal of clinical psychiatry 20040901 |
| Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report. | The Journal of clinical psychiatry 20040901 |
| [Ziprasidone and dementia]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20040826 |
| [Psychotropics and weight gain]. | Praxis 20040825 |
| Ziprasidone and mania. | The American journal of psychiatry 20040801 |
| Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride. | Movement disorders : official journal of the Movement Disorder Society 20040801 |
| [Non-information from a drug industry]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20040701 |
| [Ziprasidone-augmentation of clozapine]. | Psychiatrische Praxis 20040701 |
| Antipsychotic treatment of psychosis associated with multiple sclerosis. | Progress in neuro-psychopharmacology & biological psychiatry 20040701 |
| The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder. | The Journal of clinical psychiatry 20040701 |
| Neuroleptic malignant syndrome associated with ziprasidone in an adolescent. | Clinical therapeutics 20040701 |
| No significant QTc interval changes with high-dose ziprasidone: a case series. | Journal of psychiatric practice 20040701 |
| QTc prolongation in multiple drug overdose. | Journal of clinical psychopharmacology 20040601 |
| Combination of ziprasidone and clozapine in treatment-resistant schizophrenia. | Human psychopharmacology 20040601 |
| Ziprasidone-induced lupus erythematosus. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040601 |
| Occupancy of agonist drugs at the 5-HT1A receptor. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040501 |
| Improvement in prosocial functioning after a switch to ziprasidone treatment. | CNS spectrums 20040501 |
| A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. | The American journal of psychiatry 20040501 |
| Ziprasidone for sedation of the agitated ED patient. | The American journal of emergency medicine 20040501 |
| Use of ziprasidone to treat bipolar-associated catatonia. | Bipolar disorders 20040401 |
| Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge. | Human psychopharmacology 20040401 |
| Stability indicating reversed-phase high-performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulations. | Biomedical chromatography : BMC 20040401 |
| The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. | The Journal of clinical psychiatry 20040401 |
| Atypical antipsychotics and diabetes mellitus. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20040401 |
| Ziprasidone and mania. | Journal of the American Academy of Child and Adolescent Psychiatry 20040401 |
| [Ziprasidone. A new second-generation antipsychotic agent]. | Ugeskrift for laeger 20040329 |
| Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. | Psychopharmacology 20040301 |
| Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. | The American journal of psychiatry 20040301 |
| [Hypomania induced by Ziprasidone]. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20040301 |
| [Paralytic ileus during haloperidol therapy]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20040301 |
| Evaluating the reconstitution of intramuscular ziprasidone (Geodon) into solution. | Annals of emergency medicine 20040301 |
| Ziprasidone: a novel psychotropic with unique properties. | Expert review of neurotherapeutics 20040301 |
| Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions. | Current medicinal chemistry 20040201 |
| Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia. | Current medicinal chemistry 20040201 |
| New antipsychotics and schizophrenia: a review on efficacy and side effects. | Current medicinal chemistry 20040201 |
| Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. | The Journal of clinical psychiatry 20040201 |
| Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia. | Schizophrenia research 20040201 |
| Determination of plasma ziprasidone using liquid chromatography with fluorescence detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040125 |
| [Current pharmacotherapy of schizophrenia]. | Orvosi hetilap 20040118 |
| Ziprasidone-related tardive dyskinesia. | The American journal of psychiatry 20040101 |
| The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment. | The Journal of clinical psychiatry 20040101 |
| Hypomanic episodes after receiving ziprasidone: an unintended 'on-off-on' course of treatment. | The Journal of clinical psychiatry 20040101 |
| Ziprasidone in Parkinson's disease psychosis. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040101 |
| The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy. | International clinical psychopharmacology 20040101 |
| Atypical antipsychotics in the treatment of children and adolescents: clinical applications. | The Journal of clinical psychiatry 20040101 |
| Ziprasidone treatment of two adolescents with psychosis. | Journal of child and adolescent psychopharmacology 20040101 |
| The case for atypical antipsychotics in bipolar disorder. | Perspectives in psychiatric care 20040101 |
| Atypical antipsychotics in the treatment of affective symptoms: a review. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101 |
| The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting. | Journal of the American Medical Directors Association 20040101 |
| Ziprasidone and weight gain. | Clinical neuropharmacology 20040101 |
| The utility of intramuscular ziprasidone in the management of acute psychotic agitation. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101 |
| Intramuscular ziprasidone for acute agitation in adolescents. | Journal of child and adolescent psychopharmacology 20040101 |
| Ziprasidone monotherapy in pediatric bipolar disorder. | Journal of child and adolescent psychopharmacology 20040101 |
| The use of two neuroleptics to treat bipolar illness in two children. | Journal of child and adolescent psychopharmacology 20040101 |
| Intramuscular ziprasidone in youth: a retrospective chart review. | Journal of child and adolescent psychopharmacology 20040101 |
| Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone. | Journal of clinical psychopharmacology 20031201 |
| Extrapyramidal symptoms in children on atypical antipsychotic drugs. | Journal of clinical psychopharmacology 20031201 |
| Ziprasidone in Huntington's disease: the first case reports. | Journal of psychopharmacology (Oxford, England) 20031201 |
| Ziprasidone--not an option for serotonin syndrome. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20031125 |
| Mania from dose-related ziprasidone augmentation of an SSRI. | The Journal of clinical psychiatry 20031101 |
| Schizophrenia, VI: Treatments. | The American journal of psychiatry 20031001 |
| Possible ziprasidone-induced mania. | Journal of the American Academy of Child and Adolescent Psychiatry 20030901 |
| Ziprasidone-induced oculogyric crisis. | Journal of the American Academy of Child and Adolescent Psychiatry 20030901 |
| Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. | Bioorganic & medicinal chemistry letters 20030818 |
| Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. | Psychopharmacology 20030801 |
| Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission. | Journal of the American Academy of Child and Adolescent Psychiatry 20030801 |
| Side effects of ziprasidone. | The American journal of psychiatry 20030701 |
| Antipsychotic medication and seizures: a review. | Drugs of today (Barcelona, Spain : 1998) 20030701 |
| [Treatment of young people with atypical antipsychotic agents]. | Ugeskrift for laeger 20030602 |
| Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder. | Bipolar disorders 20030601 |
| Chlorpromazine equivalent doses for the newer atypical antipsychotics. | The Journal of clinical psychiatry 20030601 |
| Ziprasidone metabolism, aldehyde oxidase, and clinical implications. | Journal of clinical psychopharmacology 20030601 |
| Ziprasidone in autism. | Journal of the American Academy of Child and Adolescent Psychiatry 20030601 |
| A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens. | Psychopharmacology 20030501 |
| Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. | The Journal of clinical psychiatry 20030501 |
| Psychic akathisia. | Journal of clinical psychopharmacology 20030401 |
| Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. | The American journal of psychiatry 20030401 |
| A case series of ziprasidone overdoses. | Veterinary and human toxicology 20030301 |
| The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. | Journal of psychopharmacology (Oxford, England) 20030301 |
| Mania associated with initiation of ziprasidone. | The Journal of clinical psychiatry 20030301 |
| alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. | European journal of pharmacology 20030221 |
| Ziprasidone augmentation of clozapine in 11 patients. | The Journal of clinical psychiatry 20030201 |
| Ziprasidone-associated mania: a case series and review of the mechanism. | Bipolar disorders 20030201 |
| Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician. | Journal of the National Medical Association 20030201 |
| Ziprasidone-associated galactorrhea in a female teenager. | Journal of the American Academy of Child and Adolescent Psychiatry 20030101 |
| Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation. | The Journal of clinical psychiatry 20030101 |
| Prolonged erections associated with ziprasidone treatment: a case report. | The Journal of clinical psychiatry 20030101 |
| Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. | Journal of toxicology. Clinical toxicology 20030101 |
| Ziprasidone in the management of schizophrenia : the QT interval issue in context. | CNS drugs 20030101 |
| Cardiotoxicity associated with intentional ziprasidone and bupropion overdose. | Journal of toxicology. Clinical toxicology 20030101 |
| Impact of side-effects of atypical antipsychotics on non-compliance, relapse and cost. | The Journal of international medical research 20030101 |
| Ziprasidone-induced Pisa syndrome after clozapine treatment. | The Journal of neuropsychiatry and clinical neurosciences 20030101 |
| Similarities and differences among antipsychotics. | The Journal of clinical psychiatry 20030101 |
| Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management. | The Journal of clinical psychiatry 20030101 |
| The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. | The Journal of clinical psychiatry 20030101 |
| Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia. | The Journal of clinical psychiatry 20030101 |
| Oral ziprasidone in the treatment of schizophrenia: a review of short-term trials. | The Journal of clinical psychiatry 20030101 |
| Maintaining symptom control: review of ziprasidone long-term efficacy data. | The Journal of clinical psychiatry 20030101 |
| Ziprasidone and cognition: the evolving story. | The Journal of clinical psychiatry 20030101 |
| Tolerability of ziprasidone: an expanding perspective. | The Journal of clinical psychiatry 20030101 |
| Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder. | Journal of child and adolescent psychopharmacology 20030101 |
| Neuroleptic Malignant Syndrome with ziprasidone. | Journal of clinical psychopharmacology 20021201 |
| Recent developments in pharmacotherapy for the acutely psychotic patient. | Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association 20021201 |
| A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics. | The Journal of clinical psychiatry 20021201 |
| A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study. | International clinical psychopharmacology 20020901 |
| Ziprasidone alternative for olanzapine-induced hyperglycemia. | The American journal of psychiatry 20020901 |
| Continuum of care: stabilizing the acutely agitated patient. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020901 |
| Ziprasidone and migraine headache. | The American journal of psychiatry 20020801 |
| Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone. | The American journal of psychiatry 20020801 |
| Tardive dyskinesia and ziprasidone. | The American journal of psychiatry 20020801 |
| Case series: use of ziprasidone for maladaptive symptoms in youths with autism. | Journal of the American Academy of Child and Adolescent Psychiatry 20020801 |
| Priapism associated with two atypical antipsychotic agents. | Pharmacotherapy 20020801 |
| Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors. | Psychopharmacology 20020701 |
| The value of atypical antipsychotics in the treatment of schizophrenia. | Managed care (Langhorne, Pa.) 20020701 |
| Brief report on Ziprasidone. | Mymensingh medical journal : MMJ 20020701 |
| Overdose of ziprasidone. | The American journal of psychiatry 20020601 |
| Prolongation of QTc interval and antipsychotics. | The American journal of psychiatry 20020601 |
| A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia. | The Journal of clinical psychiatry 20020601 |
| [Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain]. | MMW Fortschritte der Medizin 20020506 |
| Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020501 |
| Ziprasidone: the fifth atypical antipsychotic. | The Annals of pharmacotherapy 20020501 |
| Experience with ziprasidone. | Journal of the American Academy of Child and Adolescent Psychiatry 20020501 |
| The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery. | Journal of clinical psychopharmacology 20020401 |
| Ziprasidone induction of hypomania in depression? | The American journal of psychiatry 20020401 |
| Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020301 |
| Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients. | Journal of psychiatric research 20020101 |
| Ziprasidone hydrochloride. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020101 |
| Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. | Clinical therapeutics 20020101 |
| Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited. | The Journal of clinical psychiatry 20020101 |
| Ziprasidone treatment of delirium. | Psychosomatics 20020101 |
| Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents. | CNS drugs 20020101 |
| Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. | Drugs 20020101 |
| The role of atypical antipsychotics in the treatment of delirium. | Psychosomatics 20020101 |
| Spotlight on ziprasidone in schizophrenia and schizoaffective disorder. | CNS drugs 20020101 |
| New drugs 2002, part 1. | Nursing 20020101 |
| [Schizoaffective disorder: clinical symptoms and present-day approach to treatment]. | Medicina (Kaunas, Lithuania) 20020101 |
| Comparing the side effect profile of the atypical antipsychotics. | West African journal of medicine 20020101 |
| Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation. | European journal of pharmacology 20011005 |
| Ziprasidone: profile on safety. | Expert opinion on pharmacotherapy 20011001 |
| Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. | European journal of pharmacology 20010817 |
| Use of atypical antipsychotics in mood disorders. | Current opinion in investigational drugs (London, England : 2000) 20010701 |
| Ziprasidone (Geodon) for schizophrenia. | The Medical letter on drugs and therapeutics 20010611 |
| Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT. | Neuropharmacology 20010601 |
| Ziprasidone, a new atypical antipsychotic drug. | Pharmacotherapy 20010601 |
| Ziprasidone approved. | The Harvard mental health letter 20010601 |
| Ziprasidone: a new atypical antipsychotic. | Expert opinion on pharmacotherapy 20010601 |
| Ziprasidone hydrochloride approved for treatment of schizophrenia, but with major warning. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010501 |
| Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. | Psychopharmacology 20010501 |
| The apparent effects of ziprasidone on plasma lipids and glucose. | The Journal of clinical psychiatry 20010501 |
| Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies. | Journal of clinical psychopharmacology 20010201 |
| Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. | Annual review of medicine 20010101 |
| Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. | The Journal of clinical psychiatry 20010101 |
| Sustaining short-term gains for future progress. | International clinical psychopharmacology 20010101 |
| The pharmacology of weight gain with antipsychotics. | The Journal of clinical psychiatry 20010101 |
| Psychopharmacology news. | Journal of child and adolescent psychopharmacology 20010101 |
| New schizophrenia drug. | FDA consumer 20010101 |
| Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone. | Pharmacology, biochemistry, and behavior 20010101 |
| Review of atypical antipsychotics and weight gain. | The Journal of clinical psychiatry 20010101 |
| Med-psych drug-drug interactions update. | Psychosomatics 20010101 |
| Focus on ziprasidone. | Current medical research and opinion 20010101 |
| Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations. | Psychopharmacology bulletin 20010101 |
| Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. | The Journal of pharmacology and experimental therapeutics 19951001 |